India Pesticides Posts Strong Q4 FY26 Results: Revenue Up 28.5% to ₹271 Cr, PAT Grows 40.6%
India Pesticides Limited reported strong Q4 FY26 results with revenue up 28.5% to ₹271 crore and PAT up 40.6% to ₹31 crore. FY26 revenue crossed ₹1,000 crore, reaching ₹1,078 crore, with PAT at ₹120 crore. The company projects 15-20% revenue growth for FY27 and targets ₹3,000 crore by FY31. Capex for FY27 is ₹45 crore (IPL) and ₹90 crore (subsidiary).
The results show robust financial performance with strong growth across key metrics. The company's strategic expansion, successful product launches, and clear future growth targets (₹3,000 crore by FY31) indicate a positive outlook, which is likely to significantly impact investor sentiment and the company's market position.
The company reported significant year-on-year growth in revenue, EBITDA, and PAT for both the quarter and the full year, exceeding market expectations and crossing the ₹1,000 crore revenue milestone. Strategic initiatives like capacity expansion and backward integration are progressing well, and future growth prospects appear strong.
India Pesticides Limited (IPL) has announced its audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The company reported a significant increase in revenue for the fourth quarter of FY26, reaching ₹271 crores, a growth of 28.5% compared to ₹211 crores in the same quarter of the previous year.
EBITDA for the quarter rose by 31.1% to ₹46 crores from ₹35 crores in Q4 FY25. Net profit for the quarter saw a substantial growth of 40.6% year-on-year, reaching ₹31 crores, with Profit After Tax (PAT) margins improving to 11.3%.
For the full financial year FY26, total revenue increased by 27.9% year-on-year to ₹1,078 crores, crossing the ₹1,000 crore mark for the first time. EBITDA for the year was ₹194 crores, a growth of 44.7%, with EBITDA margins improving to 18% from 15.9% in FY25. Net profit for FY26 grew by 45.8% to ₹120 crores from ₹82 crores in the previous year.
The company's performance was driven by improved capacity utilization, strong domestic and overseas demand, and operational discipline. Domestic sales in Q4 FY26 increased significantly to ₹183 crores from ₹118 crores in Q4 FY25, primarily due to strong demand for herbicides and intermediates. Export revenue for the quarter was ₹84 crores, a slight decrease from ₹89 crores in Q4 FY25 due to geopolitical issues.
IPL continues to focus on strengthening its manufacturing infrastructure, backward integration, and expanding its domestic and global presence. The Hamirpur facility's development is progressing as planned, and an intermediate plant for a herbicide has been commissioned to enhance supply chain stability and cost competitiveness. The Formulation segment capacity has scaled up to 10,000 metric tonnes, supported by a distribution network across 18 states. The company has also received multiple product registrations, strengthening its future pipeline.
Looking ahead, India Pesticides Limited anticipates a revenue increase of 15% to 20% for the current year and aims to achieve a revenue target of ₹3,000 crores by FY31. The company plans a capital expenditure of ₹45 crores for India Pesticides and ₹90 crores for its wholly-owned subsidiary in FY27, primarily funded through internal accruals. The company maintains a dividend policy of 5% to 15% of net profit, with a current credit rating of A+.
What to do with a filing like this
India Pesticides Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by India Pesticides Limited. Read the original for the full detail.